Capital Research Global Investors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.45B | Sell |
|
|||||
|
2025
Q1 | $6.12B | Sell |
|
|||||
|
2024
Q4 | $5.35B | Sell |
|
|||||
|
2024
Q3 | $5.18B | Buy |
|
|||||
|
2024
Q2 | $4.15B | Sell |
|
|||||
|
2024
Q1 | $4.49B | Buy |
|
|||||
|
2023
Q4 | $4.83B | Buy |
|
|||||
|
2023
Q3 | $4.34B | Buy |
|
|||||
|
2023
Q2 | $4.46B | Sell |
|
|||||
|
2023
Q1 | $4.84B | Buy |
|
|||||
|
2022
Q4 | $4.69B | Buy |
|
|||||
|
2022
Q3 | $3.32B | Sell |
|
|||||
|
2022
Q2 | $3.46B | Buy |
|
|||||
|
2022
Q1 | $3.33B | Sell |
|
|||||
|
2021
Q4 | $7.78B | Sell |
|
|||||
|
2021
Q3 | $8B | Sell |
|
|||||
|
2021
Q2 | $8.03B | Sell |
|
|||||
|
2021
Q1 | $7.92B | Buy |
|
|||||
|
2020
Q4 | $7.09B | Buy |
|
|||||
|
2020
Q3 | $7.4B | Sell |
|
|||||
|
2020
Q2 | $9.64B | Buy |
|
|||||
|
2020
Q1 | $7.18B | Buy |
|
|||||
|
2019
Q4 | $5.53B | Buy |
|
|||||
|
2019
Q3 | $4.87B | Sell |
|
|||||
|
2019
Q2 | $5.52B | Buy |
|
|||||
|
2019
Q1 | $5.08B | Buy |
|
|||||
|
2018
Q4 | $4.54B | Buy |
|
|||||
|
2018
Q3 | $5.39B | Buy |
|
|||||
|
2018
Q2 | $4.04B | Buy |
|
|||||
|
2018
Q1 | $3.24B | Buy |
|
|||||
|
2017
Q4 | $2.32B | Buy |
|
|||||
|
2017
Q3 | $1.77B | Buy |
|
|||||
|
2017
Q2 | $1.3B | Sell |
|
|||||
|
2017
Q1 | $1.46B | Sell |
|
|||||
|
2016
Q4 | $1.77B | Sell |
|
|||||
|
2016
Q3 | $2.21B | Buy |
|
|||||
|
2016
Q2 | $2.12B | Sell |
|
|||||
|
2016
Q1 | $2.86B | Sell |
|
|||||
|
2015
Q4 | $5.38B | Sell |
|
|||||
|
2015
Q3 | $6.87B | Sell |
|
|||||
|
2015
Q2 | $11.7B | Sell |
|
|||||
|
2015
Q1 | $9.91B | Buy |
|
|||||
|
2014
Q4 | $9.22B | Sell |
|
|||||
|
2014
Q3 | $13B | Sell |
|
|||||
|
2014
Q2 | $11.4B | Buy |
|
|||||
|
2014
Q1 | $8.71B | Sell |
|
|||||
|
2013
Q4 | $10.2B | Sell |
|
|||||
|
2013
Q3 | $9.66B | Sell |
|
|||||
|
2013
Q2 | $8.02B | Buy |
|